This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NuVasive Inc (NUVA)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 65.29M -17.50M 6.99M 2.44M
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -9.46M -18.46M -17.38M -2.00M
(Increase) Decrease in Inventories -25.98M -21.34M -21.00M -11.02M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 7.74M 22.32M 21.80M 2.94M
(Decrease) Increase In Other Current Liabilities -121.86M 37.18M -4.28M 5.13M
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00 0.00
Other Non-Cash Items 53.24M 59.44M 47.82M 47.51M
Net Cash From Continuing Operations 88.73M 115.55M 97.44M 130.08M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 88.73M 115.55M 97.44M 130.08M
Sale of Property, Plant & Equipment 40.00K 241.00K 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -107.79M -58.42M -47.60M -41.19M
Acquisitions -1.36M -500.00K -14.82M -11.09M
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 348.85M 171.02M 0.00 133.22M
Cash Provided by Financing Activities
Net Cash From Investing Activities -7.51M -104.83M -64.57M -147.89M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 12.11M 23.35M 8.42M 4.88M
Repayment of Long-Term Debt 0.00 0.00 -74.31M -29.72M
Repurchase of Capital Stock -56.93M -3.78M 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 14.48M 10.71M 13.41M 2.28M
Net Cash From Financing Activities -30.34M 30.28M -52.48M -22.56M
Effect of Exchange Rate Changes -917.00K -1.44M -861.00K 175.00K
Net Change in Cash & Cash Equivalents 49.95M 39.56M -20.47M -40.19M
NUVA News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for NUVA

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 11 10
Moderate Buy 0 0 0 0
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NUVA ANALYST REPORT

NUVA Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs